Advaxis completes patient enrollment in Phase II trial of ADXS-HPV
Patients with chemotherapy, radiotherapy or both, and whose cancer has progressed to treatment and has been confirmed by CT or radiologic scan, were randomized to the trial. Advaxis
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.
The collaborative forum is intended to facilitate the translation of scientific research findings into clinical trials and, eventually, clinical practice. Immuno-oncology focuses on the potential of body’s own
The pre-configured version of Oracle Health Sciences Empirica Topics uses BioPharm’s methodology to facilitate the formal prioritization and evaluation of signals identified within a company. BioPharm Systems safety